The importance of being able to compare: methodologies that result in the best decisions

by Ana Clopés-Estela, Ana Ortega-Eslava
Published 2021-03-01

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report

by María Espinosa Bosch, Rocío Asensi Diez, Sara García Agudo, Ana Clopes Estela
Published 2016-07-01

Drug evaluation is also a clinical activity

by Eduardo López-Briz, Mª Dolores Fraga-Fuentes, Ana Clopés-Estela, Ana Ortega-Eslava, Emilio Jesús Alegre-del Rey
Published 2021-01-01

Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages

by Juan Carlos del Río-Valencia, Rocío Asensi-Díez, M.ª Dolores Fraga-Fuentes, Ana Clopés-Estela, Lorenzo Villalobos-Torres
Published 2018-09-01

Survey of oncohematological pharmaceutical care situation in Spain

by María José Martínez-Bautista, Irene Mangues-Bafalluy, Gerardo Cajaraville-Ordoñana, María Josep Carreras-Soler, Ana Clopés-Estela, Estela Moreno-Martínez
Published 2019-11-01

Off-label use of oncology drugs: national survey results

by Eva González-Haba Peña, María José Agustín Ferrández, Irene Mangues Bafalluy, Nicolás Alfredo López, María Dolores Fraga Fuentes, Roberto Marín Gil, María José Martínez Bautista, María José Martínez Bautista, María José Martínez Bautista, Ana Clopés Estela
Published 2015-09-01